Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022
Source
Eurosurveillance : European communicable disease bulletin - ISSN 1560-7917-30:10 (2025) p. 1-18
Effectiveness of the XBB.1.5 COVID-19 vaccines against SARS-CoV-2 hospitalisation among adults aged ≥ 65 years during the BA.2.86/JN.1 predominant period, VEBIS hospital study, Europe, November 2023 to May 2024.
Source
Influenza & Other Respiratory Viruses - ISSN 1750-2659-19:3 (2025) p. 1-7
Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions : an epidemiological and transmission modelling study
Source
The Lancet Microbe - ISSN 2666-5247- (2025) p. 1-22
Emergence of the B.1.214.2 SARS-CoV-2 lineage with an Omicron-like spike insertion and a unique upper airway immune signature
Source
BMC infectious diseases - ISSN 1471-2334-24:1 (2024) p. 1-18
Epidemiology and genetic diversity of linezolid resistant enterococci clinical isolates in Belgium from 2013 to 2021
Source
Journal of Global Antimicrobial Resistance - ISSN 2213-7165-38 (2024) p. 21-26